Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis

References

• Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999;30:3540–5.
   Google Scholar
• Horowitz MC, Xi Y, Wilson K, Kacena MA. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001;12:9–18.
   PubMed Web of Science ®Google Scholar
• Bezerra MM, de Lima V, Alencar VB, Vieira IB, Brito GA, Ribeiro RA, Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000;71:1009–14.
   PubMed Web of Science ®Google Scholar
• Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M, Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380–7.
   PubMed Web of Science ®Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;15:337–42.
   Google Scholar
• Qian Y, Huang HZ. The role of RANKL and MMP-9 in the bone resorption caused by Ameloblastoma. J Oral Pathol Med 2010;39:592–8.
   PubMed Web of Science ®Google Scholar
• da Silva TA, Batista AC, Mendonça EF, Leles CR, Fukada S, Cunha FQ. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:333–41.
   PubMed Web of Science ®Google Scholar
• Chuang FH, Hsue SS, Wu CW, Chen YK. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma. J Oral Pathol Med 2009;38:753–8.
   PubMed Web of Science ®Google Scholar
• Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005;76:2033–41.
   PubMed Web of Science ®Google Scholar
• Liu D, Xu JK, Figliomeni L, Huang L, Pavlos NJ, Rogers M, Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 2003;11:17–21.
   PubMed Web of Science ®Google Scholar
• Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166–9.
   PubMed Web of Science ®Google Scholar
• Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J. Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol 2004;75:1586–91.
   PubMed Web of Science ®Google Scholar
• Nishijima Y, Yamaguchi M, Kojima T, Aihara N, Nakajima R, Kasai K. Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro.. Orthod Craniofac Res 2006;9:63–70.
   PubMedGoogle Scholar
• Oshiro T, Shiotani A, Shibasaki Y, Sasaki T. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat Rec 2002;1:218–25.
   Google Scholar
• Kawasaki K, Takahashi T, Yamaguchi M, Kasai K. Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement. Orthod Craniofac Res 2006;9:137–42.
   PubMedGoogle Scholar
• Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 2006;41:354–60.
   PubMed Web of Science ®Google Scholar
• Dereka XE, Markopoulou CE, Fanourakis G, Tseleni-Balafouta S, Vrotsos IA. RANKL and OPG mRNA level after non-surgical periodontal treatment. Inflammation 2010;33:200–6.
   PubMed Web of Science ®Google Scholar
• Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006;169:987–98.
   PubMed Web of Science ®Google Scholar
• Valverde P, Kawai T, Taubman MA. Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease. J Dent Res 2005;84:488–99.
   PubMed Web of Science ®Google Scholar
• Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 2007;42:287–93.
   PubMed Web of Science ®Google Scholar
• Han X, Kawai T, Taubman M. Interference with immune-cell-mediated bone resorption in periodontal disease. Periodontol 2000 2007;45:76–94.
   PubMed Web of Science ®Google Scholar